LAPIX
Live / Applied — Fourth extension granted (statement of use) (as of 12 Mar 2026)
What this means for you
Not registered yet, but its 23 Mar 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97853533
- Mark type
- Stylized text
- Filed
- 23 Mar 2023
- Published for opposition
- 16 Jan 2024
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for treatment of autoimmune conditions, oncological conditions, immune hyper activity, immune intolerance, and allergies
- Class 031 — Natural agricultural products: Live laboratory testing animal used to predict the human response to antigens
- Class 042 — Scientific and technological services: Providing scientific research testing services to predict the human response to antigens
- Class 044 — Medical, beauty and agricultural services: Providing medical testing for diagnostic or treatment purposes to predict the human response to antigens
Owner
- Lapix Therapeutics, Inc., Boston, MA, US
- Lapix Therapeutics, Inc., Boston, MA, US
Prosecution history
- 13 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Mar 2026 — SOU EXTENSION 4 GRANTED
- 12 Mar 2026 — SOU EXTENSION 4 FILED
- 12 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Sept 2025 — SOU EXTENSION 3 GRANTED
- 04 Sept 2025 — SOU EXTENSION 3 FILED
- 04 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 13 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Mar 2025 — SOU EXTENSION 2 GRANTED
- 12 Mar 2025 — SOU EXTENSION 2 FILED
- 12 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 10 Sept 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2024 — SOU EXTENSION 1 GRANTED
- 10 Sept 2024 — SOU EXTENSION 1 FILED